| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/29/2026 | ±3.1% | +0.5% | over-priced |
| 04/23/2026 | ±2.5% | -2.7% | under-priced |
| 10/23/2025 | ±2.0% | +0.3% | over-priced |
| 07/29/2025 | ±1.9% | +7.8% | under-priced |
| 04/24/2025 | ±3.5% | +0.7% | over-priced |
| 10/24/2024 | ±1.7% | +8.4% | under-priced |
| 07/25/2024 | ±2.1% | +9.3% | under-priced |
| 05/03/2024 | ±1.8% | -0.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.69 | $11.2B | $247M |
| Q1 FY2026 | $1.07 | $10.5B | $342M |
| Q4 FY2025 | $1.39 | $11.6B | $450M |
| Q3 FY2025 | $1.21 | $10.3B | $396M |
CBRE GROUP, INC. (CBRE) reports in 75 days, with the next report estimated for 11/21/2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 3.7% on average — the market has been roughly fair on CBRE's earnings risk. Fundamentals into the print: EPS down 4.2% year-over-year, revenue up 15.1%. QuantLogix's live 5-factor engine currently reads CBRE as a underweight at 37/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →